Patients and Industry: Starting Our New Life Together in 2023
Society for Participatory Medicine
FEBRUARY 1, 2023
Our honeymoon commenced in April with what some pharmaceutical sponsors refer to as a “mandate” to show proof of a diversity, equity, and inclusion plan “as soon as practical” in the new drug application process, further solidified by the passage of the omnibus spending package at the end of 2022.
144 
Let's personalize your content